37 “Know How": Implementación y uso de suero autólogo e insulina tópica en el Hospital San Juan de Dios BIBLIOGRAFÍA 1. Sánchez, E., Cumsille, C., Vinet, M., & Díaz, C. (2021). Elaboración de suero autólogo en el Servicio de Oftalmología (Protocolo institucional DOC–OFT 4, Edición 1; elaboración: junio 2021; vigencia: octubre 2026). Hospital San Juan de Dios–CDT, Servicio de Oftalmología, Servicio de Salud Metropolitano Occidente, Santiago, Chile. 2. Fox, R. I., Chan, R., Michelson, J. B., Belmont, J. B., & Michelson, P. E. (1984). Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis & Rheumatism, 27(4), 459–461. 3. Tsubota, K., Goto, E., Fujita, H., Ono, M., Inoue, H., Saito, I., & Shimmura, S. (1999). Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology, 106(10), 1984– 1989. 4. Eberle, J., Habermann, J., & Gürtler, L. G. (2000). HIV-1 infection transmitted by serum droplets into the eye: A case report. AIDS, 14(2), 206. 5. Poon, A. C., Geerling, G., Dart, J. K., Fraenkel, G. E., & Daniels, J. T. (2001). Autologous serum eyedrops for dry eyes and epithelial defects: Clinical and in vitro toxicity studies. British Journal of Ophthalmology, 85(10), 1188–1197. 6. Geerling, G., MacLennan, S., & Hartwig, D. (2004). Autologous serum eye drops for ocular surface disorders. British Journal of Ophthalmology, 88(11), 1467–1474. 7. Lagnado, R., King, A. J., & Dua, H. S. (2004). A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. British Journal of Ophthalmology, 88(4), 464–465. https://doi.org/10.1136/bjo.2003.037440 8. Noble, B. A., Loh, R. S., MacLennan, S., Pesudovs, K., Reynolds, A., Bridges, L. R., & Burr, J. M. (2004). Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. British Journal of Ophthalmology, 88(5), 647–652. 9. Partal, A., & Scott, E. (2011). Low-cost protocol for the production of autologous serum eye drops by blood collection and processing centres for the treatment of ocular surface diseases. Transfusion Medicine, 21(4), 271–277. https://doi.org/10.1111/ j.1365-3148.2011.01072.x 10. Lee, H. R., Hong, Y. J., Chung, S., Hwang, S. M., Kim, T. S., Song, E. Y., Park, K. U., Song, J., & Han, K. S. (2014). Proposal of standardized guidelines for the production and quality control of autologous serum eye drops in Korea: Based on a nationwide survey. Transfusion, 54(7), 1864–1870. https://doi. org/10.1111/trf.12558 11. Pan, Q., Angelina, A., Marrone, M., Stark, W. J., & Akpek, E. K. (2017). Autologous serum eye drops for dry eye. Cochrane Database of Systematic Reviews, (2), CD009327. https://doi.org/10.1002/14651858. CD009327.pub3 12. Franchini, M., Cruciani, M., Mengoli, C., Marano, G., Capuzzo, E., Pati, I., Masiello, F., Veropalumbo, E., Pupella, S., Vaglio, S., & Liumbruno, G. M. (2019). Serum eye drops for the treatment of ocular surface diseases: A systematic review and metaanalysis. Blood Transfusion, 17, 200–209. https:// doi.org/10.2450/2019.0080-19 13. Castro Mora, M. P., Palacio Varona, J., Pérez Riaño, B., Laverde Cubides, C., & Rey-Rodríguez, D. V. (2023). Effectiveness of topical insulin for the treatment of surface corneal pathologies. Archivos de la Sociedad Española de Oftalmología, 98(4), 220–232. https://doi.org/10.1016/j. oftale.2023.03.007 14. He, C.-Z., Zeng, Z.-J., Liu, J. Q., Qiu, Q., & He, Y. (2024). Autologous serum eye drops for patients with dry eye disease: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine, 11, 1430785. https://doi. org/10.3389/fmed.2024.1430785 15. Radulescu, R. B., Ferrari, S., & Ponzin, D. (2024). Topical insulin as a novel treatment for persistent epithelial defects and other ocular surface disorders: A systematic review. medRxiv (preprint). https://doi.org/10.1101/2024.10.25.24316042
RkJQdWJsaXNoZXIy MTYwMjk1